Cyanotech Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Matthew Keith Custer
- Full Time Employees
- 77
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 73-4460 Queen Kaahumanu Highway Kailua-Kona HI United States of America 96740
- IPO Date
- May 21, 1991
- CIK
- 0000768408
- Website
- cyanotech.com
- Similar Companies
- Business
- Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based nutrition and health products, engages in the sustainable cultivation, production, and sale of high-value natural ingredients and dietary supplements derived from Hawaiian microalgae. The company offers Spirulina Pacifica, a nutrient-rich whole microalgae supplement high in protein, vitamins, minerals, phycocyanin, and antioxidants including beta-carotene; BioAstin Hawaiian Astaxanthin, a potent natural antioxidant for human nutritional supplements supporting joint, eye, skin, and athletic performance in oleoresin and water-dispersible powder formats; and NatuRose Astaxanthin, a natural pigment and antioxidant for animal feed applications, particularly aquaculture to enhance fish and shrimp color and health. These products serve the human nutritional supplement, food, beverage, personal care, pet, and animal feed markets through bulk ingredient sales, branded Nutrex Hawaii consumer products, and contract extraction services utilizing supercritical carbon dioxide technology. Founded in 1983 and headquartered at 73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, Hawaii, the company operates a 90-acre open-pond cultivation facility at the Natural Energy Laboratory of Hawaii Authority, leveraging year-round sunlight, pristine ocean water via patented Ocean-Chill Drying technology, and a biosecure zone free of genetically modified organisms to ensure product quality under third-party GMP certification for dietary supplements. In recent developments, Cyanotech reported net sales growth of 19.3% to $6.976 million for the second quarter of fiscal 2026 ended September 30, 2025, with gross profit margin expanding to 34.3% from 25.3% year-over-year, driven by higher bulk astaxanthin and spirulina sales, strong online Nutrex brand performance, production efficiencies, and implemented price increases, achieving near-breakeven net income of $1,000 versus a prior-year loss. The company continues to focus on stabilizing production volumes, rationalizing market channels, emphasizing higher-margin consumer products, and exploring additional bulk sales opportunities domestically and internationally amid tariff challenges affecting contract extraction competitiveness. Earlier expansions include the 2021 acquisition of RE Botanicals, Inc. to enter consumer packaged goods, and the 2018 purchase of Cellana LLC's six-acre Kona Demonstration Facility to enhance research, development, production capacity, and new product exploration.
Contrasting Cyanotech (OTCMKTS:CYAN) & Charlie’s (OTCMKTS:CHUCD)
Cyanotech Corporation (CYAN) Q2 2026 Earnings Call Prepared Remarks Transcript
Cyanotech Reports Financial Results for the Second Quarter of Fiscal 2026
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2026
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025
Spirulina Beverages Market and Consumer Behaviour Analysis, 2025-2030 - Prolgae Spirulina Supplies, Cyanotech Corporation, FUL Foods, Sol-Ti, and Raw Juicery Lead the Projected $61 Million Market
CYAN Stock Surges 6.58% on U.S. OTC Market Amid Sector Decline
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2024
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024
Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment
Top 5 Defensive Stocks That Are Set To Fly
Volume Breakout Report Update: Buy Eton Pharmaceuticals
3 Small-Cap Bargains: Volume Breakout Report Update
Volume Breakout Report: June 25, 2022
The ESG Future Of Food Protein Production: Cyanotech
Small cap movers: CyanConnode and Sareum shares rise after they tap the market
Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks
Carotenoids Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
Cyanotech Corp (NASDAQ:CYAN) Director Michael A. / Davis Acquires 4,241 Shares of Stock